Applicability of the World Health Organization recommended new shorter regimen in a multidrug-resistant tuberculosis high burden country

被引：33
|
作者：
Javaid, Arshad [1 ]
Ahmad, Nafees [2 ,3 ]
Khan, Amer Hayat [2 ]
Shaheen, Zubair [4 ]
机构：
[1] Lady Reading Hosp Peshawar, Dept Pulmonol, Peshawar, Pakistan
[2] Univ Sains Malaysia Pulau Pinang, Sch Pharmaceut Sci, Discipline Clin Pharm, Gelugor, Penang, Malaysia
[3] Univ Baluchistan, Fac Pharm & Hlth Sci, Quetta, Pakistan
[4] Nishtar Hosp, Dept Pulmonol, Multan, Pakistan
来源：
EUROPEAN RESPIRATORY JOURNAL | 2017年 / 49卷 / 01期
关键词：
TREATMENT OUTCOMES; FLUOROQUINOLONES;
D O I：
10.1183/13993003.01967-2016
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
引用
收藏
页数：4
相关论文
共 50 条
  • [21] Benefit of the Shorter Multidrug-Resistant Tuberculosis Treatment Regimen in California and Modified Eligibility Criteria Reply
    van Leth, Frank
    Guenther, Gunar
    Hoffmann, Harald
    Lange, Christoph
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2017, 196 (11) : 1489 - 1490
  • [22] Comparative effectiveness of individualized longer and standardized shorter regimens in the treatment of multidrug resistant tuberculosis in a high burden country
    Wahid, Abdul
    Ghafoor, Abdul
    Khan, Abdul Wali
    Al-Worafi, Yaser Mohammed
    Latif, Abdullah
    Shahwani, Nisar Ahmed
    Atif, Muhammad
    Saleem, Fahad
    Ahmad, Nafees
    FRONTIERS IN PHARMACOLOGY, 2022, 13
  • [23] Eligibility for a Shorter Treatment Regimen for Multidrug-resistant Tuberculosis in the United States, 2011-2016
    Tsang, Clarisse A.
    Shah, Neha
    Armstrong, Lori R.
    Marks, Suzanne M.
    CLINICAL INFECTIOUS DISEASES, 2020, 70 (05) : 907 - 916
  • [24] Health outcomes of bedaquiline in the treatment of multidrug-resistant tuberculosis in selected high burden countries
    Lu, Xiaoyan
    Smare, Caitlin
    Kambili, Chrispin
    El Khoury, Antoine C.
    Wolfson, Lara J.
    BMC HEALTH SERVICES RESEARCH, 2017, 17
  • [25] Efficacy and safety of World Health Organization group 5 drugs for multidrug-resistant tuberculosis treatment
    Winters, Nicholas
    Butler-Laporte, Guillaume
    Menzies, Dick
    EUROPEAN RESPIRATORY JOURNAL, 2015, 46 (05) : 1461 - 1470
  • [26] High success and low recurrence with shorter treatment regimen for multidrug-resistant TB in Nepal
    Koirala, S.
    Shah, N. P.
    Pyakurel, P.
    Khanal, M.
    Rajbhandari, S. K.
    Pun, T.
    Shrestha, B.
    Maharjan, B.
    Karki, S.
    Tamang, K. B.
    Roggi, A.
    Kumar, A. M., V
    Ortuno-Gutierrez, N.
    PUBLIC HEALTH ACTION, 2021, 11 (01): : 38 - 45
  • [27] Isolation unit for multidrug-resistant tuberculosis patients in a low endemic country, a step towards the World Health Organization End TB Strategy
    Payen, M. C.
    Van Vooren, J. P.
    Vandenberg, O.
    Clumeck, N.
    De Wit, S.
    EPIDEMIOLOGY AND INFECTION, 2017, 145 (07): : 1368 - 1373
  • [28] Effectiveness of Shorter Treatment Regimen in Multidrug-Resistant Tuberculosis Patients in Pakistan: A Multicenter Retrospective Record Review
    Wahid, Abudl
    Ahmad, Nafees
    Ghafoor, Abdul
    Latif, Abdullah
    Saleem, Fahad
    Khan, Shereen
    Atif, Muhammad
    Iqbal, Qaiser
    AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 2021, 104 (05): : 1784 - 1791
  • [29] Resistance profile of drugs composing the "shorter" regimen for multidrug-resistant tuberculosis in Brazil, 2000-2015
    Dalcolmo, Margareth
    Gayoso, Regina
    Sotgiu, Giovanni
    D'Ambrosio, Lia
    Rocha, Jorge Luiz
    Borga, Liamar
    Fandinho, Fatima
    Braga, Jose Ueleres
    Sanchez, Denise Arakaki
    Dockhorn, Fernanda
    Centis, Rosella
    Migliori, Giovanni Battista
    EUROPEAN RESPIRATORY JOURNAL, 2017, 49 (04)
  • [30] Treatment Outcome of a Shorter Regimen Containing Clofazimine for Multidrug-resistant Tuberculosis: A Randomized Control Trial in China
    Du, Yadong
    Qiu, Chao
    Chen, Xiaohong
    Wang, Jing
    Jing, Wei
    Pan, Hongqiu
    Chen, Wei
    Liu, Yufeng
    Li, Chunxiang
    Xi, Xiu'e
    Yin, Hongyun
    Zeng, Jianfeng
    Zhang, Xia
    Xu, Tao
    Wang, Qingfeng
    Guo, Ru
    Wang, Jun
    Pang, Yu
    Chu, Naihui
    CLINICAL INFECTIOUS DISEASES, 2020, 71 (04) : 1047 - 1054
12345